Dimethylfumarate induces apoptosis in human mast cells

Area of Science:

• Immunology
• Cell Biology
• Pharmacology

Background:

• Mast cells play a significant role in modulating autoimmune conditions such as psoriasis and multiple sclerosis.
• Fumaric acid esters (FAEs) are established treatments for psoriasis, with dimethylfumarate (DMF) recently gaining approval for multiple sclerosis therapy.

Purpose of the Study:

• To investigate the cytotoxic effects of Fumaric Acid Esters (FAEs) on human mast cells.
• To elucidate the specific mechanisms by which DMF induces cell death in mast cells.

Main Methods:

• Analysis of cell death in the HMC-1 human mast cell line and primary cord blood-derived mast cells (CBMCs).
• Incubation of mast cells with fumaric acid (FA), monomethylfumarate (MMF), dimethylfumarate (DMF), and calcium bis(monomethylfumarate) (Ca-MF).
• Assessment of apoptotic markers, including Bax and Bak expression, and caspase-9 and caspase-6 activation.

Main Results:

• Dimethylfumarate (DMF) was identified as the sole FAE that potently induced apoptotic cell death in both HMC-1 cells and CBMCs.
• DMF-induced apoptosis involved upregulation of Bax and Bak, and activation of caspase-9 and caspase-6, indicating a mitochondrial pathway.
• DMF enhanced the susceptibility of CBMCs to apoptosis induced by TRAIL and dexamethasone.

Conclusions:

• Dimethylfumarate (DMF) induces apoptosis in human mast cells, primarily through the mitochondrial apoptotic pathway.
• These findings provide a mechanistic understanding for the therapeutic benefits of FAEs in autoimmune diseases.
• The study suggests potential for FAEs in treating other mast cell-associated disorders.